Market Overview

Goldman Sachs Reiterates Neutral on Amarin Ahead of Advisory Panel


In a report published Wednesday, Goldman Sachs analyst Gary Nachman reiterated a Neutral rating and $6.80 price target on Amarin Corporation plc (NASDAQ: AMRN).

In the report, Goldman Sachs noted, “Given that the upcoming advisory panel for AMRN's Vascepa in the expanded ANCHOR indication on Oct. 16 is such an important catalyst (followed by the PDUFA on Dec. 20), we wanted to try and frame the potential outcomes and what we think it could mean to the stock, as well as provide an options strategy. We continue to believe there is a greater than 50% chance for a favorable outcome (we estimate ~60%). However, we view the overall risk/reward in the stock going into this event as being less favorable given reasonably high expectations. We remain Neutral.”

Amarin Corporation plc closed on Tuesday at $6.69.

Latest Ratings for AMRN

Sep 2020SVB LeerinkMaintainsOutperform
Aug 2020Piper SandlerInitiates Coverage OnOverweight
May 2020Aegis CapitalMaintainsBuy

View More Analyst Ratings for AMRN
View the Latest Analyst Ratings


Related Articles (AMRN)

View Comments and Join the Discussion!

Posted-In: Gary Nachman Goldman SachsAnalyst Color Reiteration Analyst Ratings

Latest Ratings

MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at